M
Marko Duvnjak
Researcher at University of Zagreb
Publications - 84
Citations - 1677
Marko Duvnjak is an academic researcher from University of Zagreb. The author has contributed to research in topics: Nonalcoholic fatty liver disease & Cirrhosis. The author has an hindex of 18, co-authored 84 publications receiving 1551 citations.
Papers
More filters
Journal Article
Therapy with interferon alfa and ribavirin in patients with chronic hepatitis C and normal levels of alanine aminotransferase
TL;DR: Patients with mild chronic hepatitis C and normal ALT levels respond well to combination therapy with interferon and ribavirin, similar to those with elevated ALTs, and this might be a beneficial treatment option.
A new gastric juice peptide, BPC - an overview of stomach (stress) organoprotection hypothesis and BPC befitial effects
Predrag Sikiric,Marijan Petek,Sven Seiwerth,Grabarević, Željko, Rotkvić, Ivo,Branko Turkovic,Vjekoslav Jagić,Boris Mildner,Marko Duvnjak,Nada Lang,Žarko Danilović,A. Cviko,Csaba Dohoczky,M. Kolega,Ahmet Sallmani,Sanja Đačić,Miljenko Bura,Tomislav Brkić,Marko Banić,Milan Dodig,V. Corić,Velimir N. Šimičević,Marija Veljača,Damir Erceg,Damir Ježek,Lj. Šimunić-Banek,N. Skroza,Krešimir Bulić,M. Hanzevacki,Dražen Lučinger,Josip Čulig,Jadranka Separovic,Anton Marovic,Stjepan Mise,Ernest Suchanek,Wendy Matoz,Daniela Perović,Miroslav Gjurašin,Simon. Mikulandra,K. Derniković,Višeslav Ćuk,Ivan Karakaš +40 more
TL;DR: It seems that BPC treatment does not share any of the so far known limitations for "conventional organoprotectors", and whether BPC, as a likely endogenous free radical scavenger and Organoprotection mediator, would be a useful prototype of a new class of drugs, organoprotsective agents, remains to be seen.
Virusni hepatitis: Hrvatska konsenzus konferencija 2013
Adriana Vince,Irena Hrstić,Josip Begovac,Nikola Bradarić,Vesna Čolić-Cvrlje,Marko Duvnjak,Okravija Đaković-Rode,Tajana Filipec-Kanižaj,Ivica Grgurević,Alemka Jaklin-Kekez,Bernard Kaić,Petar Kes,Ivan Kurelac,Sandra Milić,Miro Morović,Anna Mrzljak,Rajko Ostojić,Mario Poljak,Jasna Slaviček,Martina Smolić,Davor Štimac,Aleksandar Včev,Boris Vucelić,Snježana Židovec-Lepej +23 more
TL;DR: For instance, this paper reported that 30 % stanovništva Zemlje (oko dvije milijarde osoba) bilo u kontaktu s HBV, a više od 360 milijuna ljudi kronično inficirano virusom hepatitisa B.
Journal Article
Viralhepatitis. Croatian Consensus Statement 2013
Adriana Vince,Irena Hrstić,Josip Begovac,Nikola Bradarić,Vesna Čolić-Cvrlje,Marko Duvnjak,Oktavija Dakovic Rode,Tajana Filipec Kanizaj,Ivica Grgurević,Alemka Jaklin Kekez,Bernard Kaić,Petar Kes,Ivan Kurelac,Sandra Milić,Miro Morović,Anna Mrzljak,Rajko Ostojić,Mario Poljak,Jasna Slaviček,Martina Smolić,Davor Štimac,Aleksandar Včev,B. Vucelić,Snjezana Zidovec Lepej +23 more
TL;DR: The abridged text of the Croatian Consensus Conference on Viral Hepatitis 2013 presents the new concepts on the epidemiology of viral hepatitis, serologic and molecular diagnosis of viral liver disease, determination of the IL-28 gene promoter polymorphism, fibrosis grading, algorithm for patient diagnostic follow up, treatment of chronic hepatitis C and hepatitis B, and therapy side effects.
Journal Article
A Randomized, Double-Blind Trial of the Efficacy of Octreotide Acetate Administration in the Prevention of Abdominal Pain Following Therapeutic Endoscopic Retrograde Cholangiopancreatography
Marko Duvnjak,Vladimir Supanc,Velimir N. Šimičević,Davor Hrabar,Branko Troskot,Rajko Ostojić,Senka Radošević +6 more
TL;DR: A randomized, double-blind trial of the efficacy of octreotide acetate administration in the prevention of abdominal pain following therapeutic endoscopic retrograde cholangiopancreatography is presented in this article.